關鍵數據
16.940今開
16.940最高
469.24K成交量
虧損本益比TTM
15.25本益比動
--股利TTM
0.13%換手率
16.990昨收
16.385最低
4.73M成交額
虧損本益比靜
0.93市淨率
0.00%股息率 TTM
-1.55%ROA
18.91552週最高
0.74量比
-317.00M淨利潤
354.21M總股本
-0.6165每股盈餘TTM
0.58Beta
-3.44%ROE
11.22052週最低
3.27%振幅
58.11%毛利率
5.99B總市值
-0.38回報/風險
1.85%風險率
操作建議
Bausch + Lomb Corp當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名94/199位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為18.55。中期看,股價處於平穩狀態。近一個月,市場表現一般,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
壓力支撐

由於公司未披露,未能獲取相關數據
Bausch + Lomb Corp新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Zimmer Biomet Holdings Inc
ZBH
31
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Bausch + Lomb Corp簡介
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
公司代碼BLCO
公司Bausch + Lomb Corp
CEOSaunders (Brenton L)
網址https://ir.bausch.com/
公司股東
常見問題
Bausch + Lomb Corp(BLCO)的當前股價是多少?
Bausch + Lomb Corp(BLCO)的當前股價是 16.91。
Bausch + Lomb Corp 的股票代碼是什麼?
Bausch + Lomb Corp的股票代碼是BLCO。
Bausch + Lomb Corp股票的52週最高點是多少?
Bausch + Lomb Corp股票的52週最高點是18.91。
Bausch + Lomb Corp股票的52週最低點是多少?
Bausch + Lomb Corp股票的52週最低點是11.22。
Bausch + Lomb Corp的市值是多少?
Bausch + Lomb Corp的市值是5.99B。
現在Bausch + Lomb Corp(BLCO)的股票是買入、持有還是賣出?
根據分析師評級,Bausch + Lomb Corp(BLCO)的總體評級為signal_hold,目標價格為18.55。
Bausch + Lomb Corp(BLCO)股票的每股收益(EPS TTM)是多少
Bausch + Lomb Corp(BLCO)股票的每股收益(EPS TTM)是-1.02。